IMRA 13F Hedge Fund and Asset Management Owners

IMARA Inc. (IMRA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

116 HUNTINGTON AVENUE BOSTON, MA 02116

Imara Inc. operates as a biopharmaceutical company. The Company develops novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. IMARA serves customers worldwide.

Data as of 2021-01-23
Market Cap	244.4 Million	Shares Outstanding	17.407 Million	Avg 30-day Volume	164.62 Thousand
P/E Ratio	-2.2	Dividend Yield		EPS	-6.38
Price/Sales		Price cash flow ratio		Price free cash flow ratio	-8.4
Book Value	5.44	Price to Tangible Book	2.58	Alpha	-0.05
Short Interest Ratio		% Short Interest to Float		R-squared	0.197103
BETA	3.29794	52-week High/Low	62.71 / 12.9	Stddev	0.410842

Q3 2020	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change
In top 10:	0	1	-100.0%	0 (0.0%)	0 (0.0%)
Funds Holding:	32	35	-8.57%	6 (0.39%)	8 (0.52%)	-25.0%
13F shares:	11.227 Million	10.935 Million	2.67%	3.941 Million	4.452 Million	-11.48%
% Ownership	64.8033	63.2782	2.41%	22.75	25.7652	-11.7%
New Positions:	2	24	-91.67%		4
Increased Positions	8	4	100.0%	2
Closed Positions	4	6	-33.33%	2	5	-60.0%
Reduced Positions	16	4	300.0%	3	3	0.0%
Total Calls		0
Total Puts		0
PUT/CALL Ratio
¹ hedge funds and active managers as identified by whalewisdom.com through public filings.

Q3 2020

All 13F Filers

Prior

Change

Hedge Funds ¹

Prior

Change

In top 10:

-100.0%

0 (0.0%)

Funds Holding:

-8.57%

6 (0.39%)

8 (0.52%)

-25.0%

13F shares:

11.227 Million

10.935 Million

2.67%

3.941 Million

4.452 Million

-11.48%

% Ownership

64.8033

63.2782

2.41%

22.75

25.7652

-11.7%

New Positions:

-91.67%

Increased Positions

100.0%

Closed Positions

-33.33%

-60.0%

Reduced Positions

300.0%

0.0%

Total Calls

Total Puts

PUT/CALL Ratio

¹ hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding IMRA (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Click for Additional Filters

Market Value:

Ranking:

% of portfolio

Refresh

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMRA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

6.3 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

6.3 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name	Type	Last Reported Date	Filings in past year
BALLAL RAHUL D. CHIEF EXECUTIVE OFFICER	Officer	2020-12-17	2
GRAY MICHAEL CFO & COO	Officer	2020-12-11	1
CONNER EDWARD R.	Director	2020-04-22	2

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER	2020-12-21 16:47:04 -0500	2020-12-17	M	4,999		d	263,999	direct
BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER	2020-12-21 16:47:04 -0500	2020-12-17	S	4,999	$25.00	d	0	direct	yes	-3.9693	-8.9629	0.0	1	-9.7738	5
BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER	2020-12-21 16:47:04 -0500	2020-12-17	M	4,999	$3.15	a	4,999	direct		-3.9693	-8.9629	0.0	1	-9.7738	5
BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER	2020-12-16 16:15:02 -0500	2020-12-14	M	1		d	268,998	direct
BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER	2020-12-16 16:15:02 -0500	2020-12-14	S	1	$25.00	d	0	direct	yes	-0.0838	-7.7503	0.0	1	-7.7503	6
BALLAL RAHUL D. - Officer CHIEF EXECUTIVE OFFICER	2020-12-16 16:15:02 -0500	2020-12-14	M	1	$3.15	a	1	direct		-0.0838	-7.7503	0.0	1	-7.7503	6
GRAY MICHAEL - Officer CFO & COO	2020-12-15 16:26:20 -0500	2020-12-11	M	1,250	$4.92	a	1,250	direct		-1.0775	-6.7551	0.0	1	-6.7551	6
GRAY MICHAEL - Officer CFO & COO	2020-12-15 16:26:20 -0500	2020-12-11	M	1,250		d	223,059	direct
GRAY MICHAEL - Officer CFO & COO	2020-12-15 16:26:20 -0500	2020-12-11	S	1,250	$25.00	d	0	direct	yes	-1.0775	-6.7551	0.0	1	-6.7551	6

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IMARA Inc. Chart by YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings